- Second Sight ( NASDAQ: EYES ) said its shareholders approved its merger with Nano Precision Medical, changing the company's name to Vivani Medical Inc. and a reverse stock split among other proposals, at the annual meeting.
- In February, Second Sight said it was merging with Nano in an all-stock deal, post which EYES shareholders would own ~23% of the combined company.
- The company said ~20.03M votes were cast in favor and ~420.4K votes were against the merger.
- Second Sight shareholders also approved a reverse stock split of its common stock as determined by the board in a ratio ranging between 1:2 and 1:10.
- The stockholders elected each of the six director nominees to the board, among other things.
- EYES +7.07% to $1.97 premarket July 29
For further details see:
Second Sight stock rises as shareholders approve merger, name change, reverse stock split